Sarepta Therapeutics, Inc.SRPTNASDAQ
Loading
Gross Profit Growth Under PressureDecelerating
Percentile Rank21
Studio
Year-over-Year Change

Year-over-year gross profit growth rate

Percentile
P21
Within normal range
vs 5Y Ago
-0.4x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
2025-16.81%
202444.82%
202337.83%
202231.11%
202126.88%
202047.02%
201921.51%
201881.24%
20172682.67%
2016103.65%